Story perspectives

Biopreservation Market to Double by 2032, Driven by Innovation

9/18/2025

Summary

Story summary

The biopreservation market is set to grow from USD 2.76 billion in 2024 to USD 5.52 billion by 2032, with a CAGR of 9.15%.
North America will lead this growth, driven by advanced healthcare and increasing cancer cases, expected to reach 3.83 million by 2045.
Innovations like DMSO-free cryopreservation media and smart cold-chain solutions improve product viability.
Challenges include high equipment costs and regulatory compliance in low- and middle-income regions.
Key players include BioLife Solutions, Thermo Fisher Scientific, and X-Therma, enhancing their biopreservation technologies.

History

Historical Context

The biopreservation market's growth follows the 2003 completion of the Human Genome Project, which advanced genetic research through a $3 billion investment by the National Institutes of Health. As cancer cases in North America are projected to reach 3.83 million by 2045, the demand for effective biopreservation technologies rises, underscoring the need for regulatory frameworks and affordable healthcare solutions.

1 of 2

Story summary

The biopreservation market is set to grow from USD 2.76 billion in 2024 to USD 5.52 billion by 2032, with a CAGR of 9.15%.
North America will lead this growth, driven by advanced healthcare and increasing cancer cases, expected to reach 3.83 million by 2045.
Innovations like DMSO-free cryopreservation media and smart cold-chain solutions improve product viability.
Challenges include high equipment costs and regulatory compliance in low- and middle-income regions.
Key players include BioLife Solutions, Thermo Fisher Scientific, and X-Therma, enhancing their biopreservation technologies.

1 / 2